BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16918128)

  • 1. Gliomatosis cerebri treatment in 11 elderly patients.
    Piccirilli M; Landi A; Salvati M
    J Exp Clin Cancer Res; 2006 Jun; 25(2):183-7. PubMed ID: 16918128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial chemotherapy in gliomatosis cerebri.
    Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
    Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliomatosis cerebri: better definition, better treatment.
    Chamberlain MC
    Neurology; 2004 Jul; 63(2):204-5. PubMed ID: 15277608
    [No Abstract]   [Full Text] [Related]  

  • 4. Procarbazine and CCNU as initial treatment in gliomatosis cerebri.
    Glas M; Rasch K; Wiewrodt D; Weller M; Herrlinger U
    Oncology; 2008; 75(3-4):182-5. PubMed ID: 18841032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant chemotherapy for gliomatosis cerebri.
    Kong DS; Kim ST; Lee JI; Suh YL; Lim DH; Kim WS; Kwon KH; Park K; Kim JH; Nam DH
    BMC Cancer; 2010 Aug; 10():424. PubMed ID: 20704759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
    Mattox AK; Lark AL; Adamson DC
    Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
    Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
    Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on glioblastoma in the elderly.
    Brandes AA; Vastola F; Basso U; Berti F; Pinna G; Rotilio A; Gardiman M; Scienza R; Monfardini S; Ermani M
    Cancer; 2003 Feb; 97(3):657-62. PubMed ID: 12548608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
    Levin N; Gomori JM; Siegal T
    Neurology; 2004 Jul; 63(2):354-6. PubMed ID: 15277636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
    Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
    No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
    Louis E; Keime-Guibert F; Delattre JY; Sanson M
    Neurology; 2003 Jan; 60(1):151. PubMed ID: 12525747
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
    Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
    Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
    Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
    Riva M; Imbesi F; Beghi E; Galli C; Citterio A; Trapani P; Sterzi R; Collice M
    Anticancer Res; 2007; 27(2):1067-71. PubMed ID: 17465245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].
    Inoue T; Kanamori M; Sonoda Y; Watanabe M; Sasajima T; Kamisato N; Kumabe T; Tominaga T
    No Shinkei Geka; 2008 Aug; 36(8):709-15. PubMed ID: 18700534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCV chemotherapy for recurrent glioblastoma.
    Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
    Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.